Physician profile
Geraldine A Ryan
NPI 1689640609
$2,142.72
in general payments reported to CMS, 2019-2025
36 companies · $586 in 2025
The $586 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $143 · 2022: $176 · 2023: $363 · 2024: $512 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,460.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $439.68 | 2022-2025 | Ubrelvy, Vraylar |
| Lilly USA, LLC | $226.19 | 2019-2025 | Mounjaro, Zepbound, Emgality |
| Novo Nordisk INC | $120.83 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $118.42 | 2019-2024 | |
| Amgen INC. | $105.91 | 2019-2025 | Otezla, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $91.66 | 2019-2024 | Airsupra, Flumist Quadrivalent |
| Glaxosmithkline, LLC. | $86.09 | 2019-2025 | Arexvy, Shingrix, Bexsero |
| Dexcom, INC. | $71.59 | 2022-2024 | Dexcom G6 Transmitter |
| Abbott Laboratories | $64.79 | 2022-2025 | Freestyle Libre 3 |
| Otsuka America Pharmaceutical, INC. | $56.82 | 2024-2025 | Rexulti |
| Exact Sciences Corporation | $51.83 | 2023-2025 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $48.02 | 2025 | Symbravo, Auvelity |
| Aimmune Therapeutics, INC. | $48.01 | 2024-2025 | Zenpep |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.66 | 2022-2025 | Xifaxan |
| Ironshore Pharmaceuticals INC. | $40.28 | 2019-2024 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geraldine Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.